Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Meropenem infusion duration study in adult intensive care patients with sepsis
ACTRN12612000284864Phase 4Completed
- Sponsor
- Austin Hospital
- Start
- May 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of meropenem in sepsis (2 arms), sponsored by Austin Hospital. Primary endpoint: Time above mean inhibitory concentration. Started May 2009; status: completed.
02
Drugs
meropenem
03
Conditions
sepsis
Beyond the preview
Go deeper on ACTRN12612000284864.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12612000284864.